Acute kidney injury in patients with Type 2 diabetes treated with metformin

被引:0
|
作者
Bell, S. [1 ]
Farran, B. [2 ]
McGurnaghan, S. [2 ]
Colhoun, H. [2 ]
Looker, H. [2 ]
机构
[1] NHS Tayside, Renal Unit, Dundee, Scotland
[2] Univ Dundee, Div Populat Hlth Sci, Dundee, Scotland
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P172
引用
收藏
页码:85 / 85
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of acarbose in metformin-treated patients with type 2 diabetes
    Rosenstock, J
    Brown, A
    Fischer, J
    Jain, A
    Littlejohn, T
    Nadeau, D
    Sussman, A
    Taylor, T
    Krol, A
    Magner, J
    DIABETES CARE, 1998, 21 (12) : 2050 - 2055
  • [22] Association between metformin use on admission and outcomes in intensive care unit patients with acute kidney injury and type 2 diabetes: A retrospective cohort study
    Yang, Qilin
    Zheng, Jiezhao
    Wen, Deliang
    Chen, Xiaohua
    Chen, Weiyan
    Chen, Weixiao
    Xiong, Xuming
    Zhang, Zhenhui
    JOURNAL OF CRITICAL CARE, 2021, 62 : 206 - 211
  • [23] Response to Article "Are There Differences in Gut Microbiome in Patients with Type 2 Diabetes Treated by Metformin or Metformin and Insulin?"
    Panjaitan, Novaria Sari Dewi
    Lestari, Christina Safira Whinie
    Maha, Masri Sembiring
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 3889 - 3890
  • [24] Acute kidney injury associated with metformin
    Li Cavoli, Gioacchino
    Tortorici, Calogera
    Bono, Luisa
    Giammarresi, Carlo
    Ferrantelli, Angelo
    Zagarrigo, Carmela
    Schillaci, Onofrio
    Tralongo, Angelo
    Ugo, Rotolo
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2011, 29 (05): : 568 - 569
  • [25] The impact of metformin on severity of acute stroke patients with type 2 diabetes mellitus
    Mima, Y.
    Kuwashiro, T.
    Wakugawa, Y.
    Yasaka, M.
    Okada, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 280 - 281
  • [26] Acute Kidney Injury Associated With Finerenone Use in Type 2 Diabetes Mellitus Patients: A Case Report
    Srivastava, Brijendra Kumar
    Anjana, Ranjit Mohan
    Lavanya, Rajendran
    Mohan, Viswanathan
    JOURNAL OF DIABETOLOGY, 2025, 16 (01) : 89 - 91
  • [27] Effect of metformin on kidney function in patients with type 2 diabetes mellitus and moderate chronic kidney disease
    Hsu, Wei-Hao
    Hsiao, Pi-Jung
    Lin, Pi-Chen
    Chen, Szu-Chia
    Lee, Mei-Yueh
    Shin, Shyi-Jang
    ONCOTARGET, 2018, 9 (04) : 5416 - 5423
  • [28] Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
    Charytan, David M.
    Solomon, Scott D.
    Ivanovich, Peter
    Remuzzi, Giuseppe
    Cooper, Mark E.
    McGill, Janet B.
    Parving, Hans-Henrik
    Parfrey, Patrick
    Singh, Ajay K.
    Burdmann, Emmanuel A.
    Levey, Andrew S.
    Eckardt, Kai-Uwe
    McMurray, John J. V.
    Weinrauch, Larry A.
    Liu, Jiankang
    Claggett, Brian
    Lewis, Eldrin F.
    Pfeffer, Marc A.
    DIABETES OBESITY & METABOLISM, 2019, 21 (05): : 1199 - 1208
  • [29] Pharmacokinetics of metformin in patients with chronic kidney disease stage 4 and metformin-naive type 2 diabetes
    Dissanayake, Ajith M.
    Wheldon, Mark C.
    Hood, Christopher J.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2018, 6 (05):
  • [30] Exenatide improves postprandial hyperglycaemia and dyslipidaemia in metformin treated patients with type 2 diabetes
    Bunck, M. C.
    Corner, A.
    Diamant, M.
    Eliasson, B.
    Malloy, J. L.
    Shaginian, R. M.
    Deng, W.
    Kendall, D. M.
    Smith, U.
    Yki-Jarvinen, H.
    Heine, R. J.
    Taskinen, M. R.
    DIABETOLOGIA, 2008, 51 : S351 - S351